Resolution of Hereditary Hemorrhagic Telangiectasia and Anemia with Prolonged α-interferon Therapy for Chronic Hepatitis C

Journal of Clinical Gastroenterology

Volumn 38, Issue 4, 2004, Pages 377-379

  Massoud, Omar I ^a   Youssef, Wael I ^a   Mullen, Kevin D ^a  

^a METROHEALTH MEDICAL CENTER   (United States)

Author keywords

Anemia; Hepatitis C; Hereditary hemorrhagic telangiectasia; Interferon

Indexed keywords

RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN;

ADULT; ANEMIA; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CASE REPORT; CLINICAL FEATURE; DISEASE ACTIVITY; DISEASE COURSE; HEPATITIS C; HUMAN; HUMAN TISSUE; MALE; MUCOSA; PRIORITY JOURNAL; RENDU OSLER WEBER DISEASE; SKIN; TELANGIECTASIA; TREATMENT INDICATION; TREATMENT OUTCOME;

ANEMIA; ANTIVIRAL AGENTS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; TELANGIECTASIA, HEREDITARY HEMORRHAGIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 1642299483     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004836-200404000-00015     Document Type: Article

References (31)

1. Rendu HJ. Épistaxis répétées chez un sujet porteur de petits angiomes cutanés et muqueux. Gaz Hop. 1896:1322-1323.
2. Osler W. On a family form of recurring epistaxis, associated with multiple telangiectases of the skin and mucous membranes. Bull John Hopkins Hosp. 1901;12:333-337.
3. Weber FP. Multiple hereditary developmental angiomata: telangiectases of the skin and mucous membranes associated with recurring haemorrhages. Lancet. 1907;2:160-162.
4. Hanes FM. Multiple hereditary telangiectasia causing hemorrhage: hereditary hemorrhagic telangiectasia). Bull John Hopkins Hosp. 1909;20:63-73.
5. Kjeldsen AD, Vase P, Green A. Hereditary hemorrhagic telangiectasia: A population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999;245:31-39.
6. Guttmacher AE, McKinnon WC, Upton MD. Hereditary hemorrhagic telangiectasia. A disorder in search of the genetics community. Am J Med Genet. 1994;52:252-253.
7. Shovlin CL, Hughes JMB, Tuddenham EGD, et al. A gene for hereditary hemorrhagic telangiectasia maps to chromosome 9q3. Nat Genet. 1994;6:205-209.
8. Porteous MEM, Curtis A, Williams O, et al. Genetic heterogeneity in hereditary hemorrhagic telangiectasia. J Med Genet. 1994;31:925-926.
9. McAllister KA. Lennon F, Bowles-Biesecker B, et al. Genetic heterogeneity in hereditary hemorrhagic telangiectasia: possible correlation with clinical phenotype. J Med Genet. 1994;31:927-932.
10. Heutink P. Haitjema T, Breedveld GJ, et al. Linkage of hereditary hemorrhagic telangiectasia to chromosome 9q3 and evidence for locus heterogeneity. J Med Genet. 1994;31:933-936.
11. Longacre AV. Gross CP, Gallitelli M, et al. Diagnosis and management of gastrointestinal bleeding in patients with hereditary hemorrhagic telangiectasia. Am J Gastro. 2003;98:59-65.
12. Guttmacher AE. Marchuk DA, White RI. Hereditary hemorrhagic telangiectasia. N Eng J Med. 1995;333:918-922.
13. White RI Jr. Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology. 1988;169:663-669.
14. Roman G. Fisher M, Perl DP, et al. Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. Ann Neurol. 1978;4:130-144.
15. Willinsky RA. Lasjaunias P, Terbrugge K, et al. Multiple cerebral arteriovenous malformations (AVMs): review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32:207-210.
16. Haitjema T, Westermann CJ, Overtoom TT, et al. Hereditary hemorrhagic telangiectasia. Arch Intern Med. 1996;156:714-718.
17. Paluchu H. de Chadarevian JP, Bideau A, et al. Age related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet. 1989;32:291-297.
18. McAllister KA, Grogg KM, Johnson DW, et al. Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary hemorrhagic telangiectasia type 1. Nat Genet. 1994;8:345-351.
19. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia. Am J Med Genet. 2000;91:66-67.
20. Vase P. Estrogen treatment of hereditary hemorrhagic telangiectasia: a double-blind controlled clinical trial. Acta Med Scand. 1981;209:393-396.
21. Vase P, Grove O. Gastrointestinal lesions in hereditary hemorrhagic telangiectasia. Gastroenterology. 1986;91:1079-1083.
22. Porteous ME, Burn J, Proctor SJ. Hereditary hemorrhagic telangiectasia: a clinical analysis. J Med Genet. 1992;29:527-530.
23. Jesserun GAJ, Kamphuis DJ, van der Zande FHR, et al. Cerebral arteriovenous malformations in the Netherlands Antilles: high prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg. 1993;95:193-198.
24. Harrison DFN. Use of estrogen in treatment of familial hemorrhagic telangiectasia. Laryngoscope. 1982;92:314-320.
25. Garmendia G, Miranda N, Borroso S, et al. Regression of infancy hemangiomas with recombinant IFN-α2b. J Interferon Cytokine Res. 2001;21:31-38.
26. Silverman RA. Hemangiomas and vascular malformations. Ped Clin North Am. 1991;38:811-834.
27. Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987;235:442-447.
28. Ricketts RR, Hatley RM, Corden BJ, et al. Interferon-α 2a for the treatment of complex hemangiomas of infancy and childhood. Ann Surg. 1994;219:605-612.
29. Friesel R, Komoriya A, Maciag T. Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol. 1987;104:689-696.
30. Sidky YA, Borden EC. Inhibition of angiogenesis by interferons: effects on tumor-and lymphocyte-induced vascular responses. Cancer Res. 1987;47:5155-5161.
31. White CW, Wolf SJ, Korones DN, et al. Treatment of childhood angiomatous diseases with recombinant interferon-α2a. J Pediatr. 1991;118:59-66.